FindTrial
Sign In

Patients with SARSCOV-2 with its mRNA levels of Blimp1 alpha and beta

An observational Study to Asses mRNA expression levels of Blimp1 alpha and beta in SARSCoV-2 infected subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029868
Enrollment
55
Registered
2020-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B998- Other infectious disease

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

SN Medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1) Age more than 18 years and less than 60 years (2) Both gender (3) Subject with SARCoV-2 infected and uninfected confirmed by RT-PCR on nasopharyngeal swab. (4) RT-PCR confirmed SARSCoV-2 infected patients with mild, moderate, and server COVID-19 disease based on WHO criteria.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
For Primary objective successful isolation of RNA from COVID-19 patients and successful amplification of the target gene along housekeeping gene.Timepoint: after 1 month—

Secondary

MeasureTime frame
A statistical correlation between severity and lymphocyte count.Timepoint: After 1 month—

Countries

India

Contacts

Public ContactDr Nitu Chahuhan

S N Medical college

drnituchauhan26@gmail.com9717970933

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026